Paul Blanchfield
Fortune : 8 M $ au 30/06/2026
Fortune : 8 M $ au 30/06/2026
Paul Blanchfield is Chief Executive Officer & Director at Alpha-9 Oncology, Inc. since 2025.
Former roles include President at Lantheus Holdings, Inc. from 2023 to 2025, General Manager-Nordic Baltics at Shire Plc, and Head-US Immunology Business Unit at Takeda Pharmaceutical Co., Ltd. Education includes undergraduate studies at Duke University and graduate and MBA degrees from Stanford University.
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
LANTHEUS HOLDINGS INC 0,11 % | 06/03/2026 | 69 426 ( 0,11 % ) | 8 M $ | 30/06/2026 |
| Sociétés | Poste | Début |
|---|---|---|
Alpha-9 Oncology, Inc.
Alpha-9 Oncology, Inc. BiotechnologyHealth Technology Engages in research clinical stage radiopharmaceutical and drug design for cancer treatment | Directeur Général | 10/11/2025 |
| Sociétés | Poste | Fin |
|---|---|---|
| LANTHEUS HOLDINGS, INC. | President | 07/11/2025 |
Shire Plc /Old/
Shire Plc /Old/ Miscellaneous Commercial ServicesCommercial Services Develops, manufactures and markets pharmaceuticals | Corporate Officer/Principal | - |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Corporate Officer/Principal | - |
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
| Entreprise privées | 6 |
|---|---|
Shire Plc /Old/
Shire Plc /Old/ Miscellaneous Commercial ServicesCommercial Services Develops, manufactures and markets pharmaceuticals | Commercial Services |
Duke University
Duke University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Takeda Pharmaceutical Co., Ltd.
Takeda Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Engages in the research, development, manufacturing and marketing of pharmaceutical products | Health Technology |
Lantheus Holdings, Inc.
Lantheus Holdings, Inc. Medical SpecialtiesHealth Technology Manufactures, markets, sells and distributes medical imaging products | Health Technology |
Alpha-9 Oncology, Inc.
Alpha-9 Oncology, Inc. BiotechnologyHealth Technology Engages in research clinical stage radiopharmaceutical and drug design for cancer treatment | Health Technology |
Sélectionnez votre édition
Toutes les informations financières adaptées au niveau national